BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12669155)

  • 1. Characteristics of nanobacteria and their possible role in stone formation.
    Kajander EO; Ciftcioglu N; Aho K; Garcia-Cuerpo E
    Urol Res; 2003 Jun; 31(2):47-54. PubMed ID: 12669155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithogenesis: induction of renal calcifications by nanobacteria.
    Shiekh FA; Khullar M; Singh SK
    Urol Res; 2006 Feb; 34(1):53-7. PubMed ID: 16425019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxalate crystallization in the kidney in the presence of hyperuricemia.
    Noda S; Hayashi K; Eto K
    Scanning Microsc; 1989 Sep; 3(3):829-35; discussion 835-6. PubMed ID: 2617264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biopathological crystallization: a general view about the mechanisms of renal stone formation.
    Grases F; Costa-Bauzá A; García-Ferragut L
    Adv Colloid Interface Sci; 1998 Feb; 74():169-94. PubMed ID: 9561720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium stone disease: a multiform reality.
    Trinchieri A; Castelnuovo C; Lizzano R; Zanetti G
    Urol Res; 2005 Jun; 33(3):194-8. PubMed ID: 15714335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation.
    Cerini C; Geider S; Dussol B; Hennequin C; Daudon M; Veesler S; Nitsche S; Boistelle R; Berthézène P; Dupuy P; Vazi A; Berland Y; Dagorn JC; Verdier JM
    Kidney Int; 1999 May; 55(5):1776-86. PubMed ID: 10231440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanobacteria: an infectious cause for kidney stone formation.
    Ciftçioglu N; Björklund M; Kuorikoski K; Bergström K; Kajander EO
    Kidney Int; 1999 Nov; 56(5):1893-8. PubMed ID: 10571799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stone formation in human kidney.
    Hering F; Briellmann T; Lüönd G; Guggenheim H; Seiler H; Rutishauser G
    Urol Res; 1987; 15(2):67-73. PubMed ID: 3590431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathophysiology, diagnosis and conservative therapy of non-calcium kidney calculi].
    Hochreiter W; Knoll T; Hess B
    Ther Umsch; 2003 Feb; 60(2):89-97. PubMed ID: 12649987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different Approaches to Detect "Nanobacteria" in Patients with Kidney Stones: an Infectious Cause or a Subset of Life?
    Ansari H; Akhavan Sepahi A; Akhavan Sepahi M
    Urol J; 2017 Aug; 14(5):5001-5007. PubMed ID: 28853105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual roles of brushite crystals in calcium oxalate crystallization provide physicochemical mechanisms underlying renal stone formation.
    Tang R; Nancollas GH; Giocondi JL; Hoyer JR; Orme CA
    Kidney Int; 2006 Jul; 70(1):71-8. PubMed ID: 16641926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potential cause for kidney stone formation during space flights: enhanced growth of nanobacteria in microgravity.
    Ciftçioglu N; Haddad RS; Golden DC; Morrison DR; McKay DS
    Kidney Int; 2005 Feb; 67(2):483-91. PubMed ID: 15673296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanobacteria: controversial pathogens in nephrolithiasis and polycystic kidney disease.
    Kajander EO; Ciftcioglu N; Miller-Hjelle MA; Hjelle JT
    Curr Opin Nephrol Hypertens; 2001 May; 10(3):445-52. PubMed ID: 11342811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal surface adhesion explains the pathological activity of calcium oxalate hydrates in kidney stone formation.
    Sheng X; Ward MD; Wesson JA
    J Am Soc Nephrol; 2005 Jul; 16(7):1904-8. PubMed ID: 15930089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of lipids in urine, crystals and stones: implications for the formation of kidney stones.
    Khan SR; Glenton PA; Backov R; Talham DR
    Kidney Int; 2002 Dec; 62(6):2062-72. PubMed ID: 12427130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Microinfections and kidney lithiasis].
    Conte Visús A; Grases Freixedas F; Costa-Bauzá A; Pizá Reus P
    Arch Esp Urol; 2001 Nov; 54(9):855-60. PubMed ID: 11789365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Establishment nephrolithiasis rat model induced by nanobacteria and analysis of stone formation].
    Hu WG; Wang XF; Xu T; Li JX; Chen L; Yu CF; Huang XB
    Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Aug; 42(4):433-5. PubMed ID: 20721258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Infectious genesis of nephroliths (electron-microscopic study)].
    Didenko LV; Perepanova TS; Tolordava ÉR; Borovaia TG; Shevliagina NV; Égamberdiev DK; Golovanov SA; Romanova IuM
    Urologiia; 2012; (3):4-7. PubMed ID: 23074923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.